FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Newman James W. Jr.		 2. Issuer Name and Ticker or Trading Symbol

ADIAL PHARMACEUTICALS, INC. [ ADIL ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    _____ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle)

1180 SEMINOLE TRAIL, SUITE 495		 3. Date of Earliest Transaction (MM/DD/YYYY)

3/27/2020
(Street)

CHARLOTTESVILLE, VA 22901
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
 6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 3/27/2020  P  5000 A$1.42 15000 D  
Common Stock 3/27/2020  P  10000 (1)A$1.34 (1)13288 I Roundtop Limited Partnership, LLP (1)
Common Stock         41160 I Newman GST Trust FBO James W. Newman Jr. (2)
Common Stock         150419 I Virga Ventures, LLC (3)
Common Stock         35221 I Ivy Cottage Group, LLC (4)
Common Stock 3/27/2020  P  4644 A$1.35 14644 I Roth IRA FBO James W Newman, Jr. (5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)		2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)		8. Price of Derivative Security
(Instr. 5)		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
(1) James W. Newman is the general partner of Roundtop Limited Partnership, LLP.
(2) James W. Newman is the trustee of the Newman GST Trust FBO James W. Neman Jr.
(3) James W. Newman is the sole member of Virga Ventures, LLC.
(4) James W. Newman is the general partner of Ivy Cottage Group, LLC.
(5) James W. Newman is the beneficiary of this Roth IRA.
Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Newman James W. Jr.
1180 SEMINOLE TRAIL, SUITE 495
CHARLOTTESVILLE, VA 22901		X
Signatures
/s/ James W. Newman, Jr.3/30/2020
**Signature of Reporting PersonDate
Adial Pharmaceuticals (PK) (USOTC:ADIWW)
Historical Stock Chart
Von Mai 2024 bis Jun 2024 Click Here for more Adial Pharmaceuticals (PK) Charts.
Adial Pharmaceuticals (PK) (USOTC:ADIWW)
Historical Stock Chart
Von Jun 2023 bis Jun 2024 Click Here for more Adial Pharmaceuticals (PK) Charts.